Skip to content
Screener

Balchem BCPC Specialty Products — Operating Income (Loss)

Other segment segments

Human Nutrition and Health
$40.02M+5.4%
Animal Nutrition and Health
$5.69M+8.7%

Similar metrics at other companies

GTL
GTLSSpecialty Products — Operating Income (Loss)
$8.4M-82.6%
MML
MMLPSpecialty Products — Operating Income (Loss)
$4.61M+26.9%
Envista Holdings Corporation logo
NVSTSpecialty Products & Technologies — Operating Income (Loss)
$60.1M+32.7%
Amneal Pharmaceuticals, Inc. logo
AMRXSpecialty — Operating Income (Loss)
$54.86M+54.6%
Carpenter Technology logo
CRSSpecialty Alloys Operations — Operating Income (Loss)
$229.7M+34.6%
APi Group logo
APGSpecialty Services — Operating Income (Loss)
$39M+34.5%

Other financials

Income statement

See full
Revenue$270.7M+8.1%
Gross profit$101.1M+14.6%
Operating income$55.6M+9.0%
Net income$40.3M+8.7%
EPS (diluted)$1.25+10.6%

Balance sheet

See full
Cash & equivalents$72.9M+46.0%
Total debt$37.4M-1.7%
Total equity$1.3B+6.3%
Total assets$1.7B+4.7%

Cash flow

See full
Operating cash flow$40.1M+9.9%

Valuation

See full
Market cap$5.75B+10.8%
Enterprise value$5.72B+10.7%
P/E36.4×0.0×
P/S5.4×+0.2×

Profitability

See full
Gross margin36.3%+0.7pp
Operating margin20.2%+0.3pp
Net margin15%+0.8pp
FCF margin14.9%

Returns & leverage

See full
Return on equity12.7%+0.7pp
Debt / equity0.0×
Current ratio2.5×+0.1×

Where this comes from

Reported directly by Balchem in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Balchem’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:33 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000009326-26-000018
Line itemHNHANHSPOther and UnallocatedTotal
Cost of sales105,77247,20014,2642,389169,625
Gross margin65,85614,98920,463(224)101,084
Operating expenses25,8369,2978,5281,79745,458
Earnings from operations40,0205,69211,935(2,021)55,626
Other expenses:
Interest expense, net2,213
Other expense, net891
3,104

Item 1. Financial Statements (unaudited)

FAQ

What is Balchem's specialty products — operating income (loss)?
Balchem (BCPC) reported specialty products — operating income (loss) of $11.94M in Q1 2026.
How has Balchem's specialty products — operating income (loss) changed year-over-year?
Balchem's specialty products — operating income (loss) increased by 24.5% year-over-year, from $9.59M to $11.94M.
What is the long-term trend for Balchem's specialty products — operating income (loss)?
Over 3 years (2022 to 2025), Balchem's specialty products — operating income (loss) has grown at a 9.4% compound annual growth rate (CAGR), from $32.79M to $42.9M.
What does specialty products — operating income (loss) mean?
Represents the profit or loss generated by the specialty products segment after deducting both cost of sales and operating expenses from net sales. This is a primary indicator of the segment's operational health and its contribution to the overall corporate bottom line.

Ask your AI about Balchem's specialty products — operating income (loss).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude